Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paterson

Showing results (391-400 of 401) with videos related to

Pageof 41
Sort By:
Nature Structural & Molecular Biology|August 2, 2020
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patientDaming Zhou, Helen M E Duyvesteyn, Cheng-Pin Chen, et al.
Cell|July 26, 2024
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotypeJordan R Barrett, Dimitra Pipini, Nathan D Wright, et al.
American Journal of Physical Medicine & Rehabilitation|November 19, 2025
Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery and Community Participation Following Stroke. Part One: Stroke Rehabilitation Planning for Optimal Care Delivery, 7th Edition Update 2025Michelle LA Nelson, Jing Shi, M Patrice Lindsay, et al.
Cell|March 21, 2021
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine seraPiyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
Cell|April 14, 2021
Antibody evasion by the P.1 strain of SARS-CoV-2Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, et al.
The Journal of General Virology|August 29, 2015
In memoriam--Richard M. Elliott (1954-2015)Benjamin Brennan, Friedemann Weber, Richard Kormelink, et al.
Cell|March 23, 2021
The antigenic anatomy of SARS-CoV-2 receptor binding domainWanwisa Dejnirattisai, Daming Zhou, Helen M Ginn, et al.
Cell|July 9, 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumChang Liu, Helen M Ginn, Wanwisa Dejnirattisai, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Cell|January 26, 2022
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Pageof 41

Showing results (391-400 of 401) with videos related to

Sort By:
Pageof 41
Nature Structural & Molecular Biology|August 2, 2020
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patientDaming Zhou, Helen M E Duyvesteyn, Cheng-Pin Chen, et al.
Cell|July 26, 2024
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotypeJordan R Barrett, Dimitra Pipini, Nathan D Wright, et al.
American Journal of Physical Medicine & Rehabilitation|November 19, 2025
Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery and Community Participation Following Stroke. Part One: Stroke Rehabilitation Planning for Optimal Care Delivery, 7th Edition Update 2025Michelle LA Nelson, Jing Shi, M Patrice Lindsay, et al.
Cell|March 21, 2021
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine seraPiyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
Cell|April 14, 2021
Antibody evasion by the P.1 strain of SARS-CoV-2Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, et al.
The Journal of General Virology|August 29, 2015
In memoriam--Richard M. Elliott (1954-2015)Benjamin Brennan, Friedemann Weber, Richard Kormelink, et al.
Cell|March 23, 2021
The antigenic anatomy of SARS-CoV-2 receptor binding domainWanwisa Dejnirattisai, Daming Zhou, Helen M Ginn, et al.
Cell|July 9, 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumChang Liu, Helen M Ginn, Wanwisa Dejnirattisai, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Cell|January 26, 2022
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Pageof 41